Contact

Our portfolio

Inreda Diabetic

Developing a bi-hormonal artificial pancreas, Inreda Diabetic offers a closed-loop system for diabetes management. Their device automates insulin and glucagon administration, drastically reducing the burden on patients compared to classic single-hormone pumps. Inreda Diabetic’s technology aims to improve blood glucose control and quality of life for diabetes patients.

  • Institute: Amsterdam UMC
Industry: Diabetes, Medical Technology
  • Founding year: 2007
Visit website

Want to get in contact about Inreda Diabetic?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Regenesance
Engineering antibodies to treat neurodegenerative and immune diseases.
Eddytec
Providing advanced defect detection for carbon composites in aerospace and wind energy.
Arthrogen
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
Fermioniq
Combining quantum computing and classical simulations for material science.
Regenesance
Engineering antibodies to treat neurodegenerative and immune diseases.
Eddytec
Providing advanced defect detection for carbon composites in aerospace and wind energy.
Arthrogen
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
Fermioniq
Combining quantum computing and classical simulations for material science.
Explore full AAV portfolio
Contact